Credit Suisse Ag Green Light Biosciences Holdings, Pbc Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$1.03 - $2.0 $1,909 - $3,708
1,854 Added 5.64%
34,719 $40,000
Q3 2022

Nov 10, 2022
BUY
$0.42 - $3.92 $165 - $1,544
394 Added 1.21%
32,865 $76,000
Q2 2022

Aug 12, 2022
BUY
N/A
32,471 New
32,471 $72,000

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0
View Full List

About GreenLight Biosciences Holdings, PBC

GRNA Quotes by TradingView
  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email